These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27921286)

  • 21. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Liu Y
    Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
    Lu P; Sun Y; Sun Y; Yu L
    Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
    Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer?
    Ul-Hassan F; Simo R; Guerrero-Urbano T; Oakley R; Jeannon JP; Cook GJ
    Clin Nucl Med; 2013 Apr; 38(4):263-5. PubMed ID: 23429398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG uptake in cervical lymph nodes in children without head and neck cancer.
    Vali R; Bakkari A; Marie E; Kousha M; Charron M; Shammas A
    Pediatr Radiol; 2017 Jun; 47(7):860-867. PubMed ID: 28357549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.
    Yao M; Smith RB; Hoffman HT; Funk GF; Lu M; Menda Y; Graham MM; Buatti JM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):9-14. PubMed ID: 18930358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of post-treatment
    An YS; Yoon JK; Lee SJ; Jeong SH; Lee HW
    Eur Radiol; 2016 Dec; 26(12):4632-4639. PubMed ID: 27193777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
    Dresel S; Schwenzer K; Brinkbäumer K; Schmid R; Szeimies U; Pöpperl G; Hahn K
    Nuklearmedizin; 2001 Oct; 40(5):172-8. PubMed ID: 11727630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
    Dresel S; Grammerstorff J; Schwenzer K; Brinkbäumer K; Schmid R; Pfluger T; Hahn K
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):995-1003. PubMed ID: 12739070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
    Nikolova PN; Hadzhiyska VH; Mladenov KB; Ilcheva MG; Veneva S; Grudeva VV; Dineva SE; Asenov YN
    Neoplasma; 2021 Jan; 68(1):180-189. PubMed ID: 32880466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of single-photon emission computed tomography/computed tomography for sentinel lymph node localization in head and neck cutaneous malignancy.
    Remenschneider AK; Dilger AE; Wang Y; Palmer EL; Scott JA; Emerick KS
    Laryngoscope; 2015 Apr; 125(4):877-82. PubMed ID: 25388656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.
    Ishikita T; Oriuchi N; Higuchi T; Miyashita G; Arisaka Y; Paudyal B; Paudyal P; Hanaoka H; Miyakubo M; Nakasone Y; Negishi A; Yokoo S; Endo K
    Ann Nucl Med; 2010 Feb; 24(2):77-82. PubMed ID: 20058105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
    Ong SC; Schöder H; Lee NY; Patel SG; Carlson D; Fury M; Pfister DG; Shah JP; Larson SM; Kraus DH
    J Nucl Med; 2008 Apr; 49(4):532-40. PubMed ID: 18344440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
    Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.